MCCVX
Price
$22.47
Change
+$0.03 (+0.13%)
Updated
Sep 8 closing price
Net Assets
1.88B
PACIX
Price
$29.47
Change
+$0.23 (+0.79%)
Updated
Sep 8 closing price
Net Assets
1.74B
Interact to see
Advertisement

MCCVX vs PACIX

MCCVX vs PACIX Comparison Chart in %
View a ticker or compare two or three
VS
MCCVX vs. PACIX commentary
Sep 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCCVX is a Hold and PACIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MCCVX has more cash in the bank: 1.88B vs. PACIX (1.74B). PACIX (1.30) and MCCVX (1.27) have matching dividends . MCCVX was incepted earlier than PACIX: MCCVX (28 years) vs PACIX (39 years). MCCVX (1.91) is less costly to investors than PACIX (1.15). PACIX is a more actively managed with annual turnover of: 212.00 vs. MCCVX (40.00). MCCVX has a lower initial minimum investment than PACIX: MCCVX (1000) vs PACIX (2000). MCCVX (1000) and PACIX (1000) have similar IRA initial investment minimum. PACIX annual gain was more profitable for investors over the last year : 21.95 vs. MCCVX (15.42). PACIX return over 5 years is better than : 8.76 vs. MCCVX (-1.21).
MCCVXPACIXMCCVX / PACIX
Total Expense Ratio1.911.09175%
Annual Report Gross Expense Ratio1.911.15166%
Fund Existence28 years39 years-
Gain YTD17.36415.145115%
Front LoadN/A6%-
Min. Initial Investment1000200050%
Min. Initial Investment IRA10001000100%
Net Assets1.88B1.74B108%
Annual Yield % from dividends1.271.3097%
Returns for 1 year15.4221.9570%
Returns for 3 years35.1257.3261%
Returns for 5 years-1.218.76-14%
Returns for 10 years52.68102.9051%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWKS74.022.52
+3.52%
Skyworks Solutions
ESTA74.291.99
+2.75%
Establishment Labs Holdings
BACCU10.89N/A
N/A
Blue Acquisition Corp
KRAQ10.01-0.01
-0.10%
Krakacquisition Corp
ELTX2.41-0.09
-3.60%
Elicio Therapeutics